These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37087169)

  • 1. Rare diseases: democratising genetic testing in LMICs.
    Núñez-Samudio V; Arcos-Burgos M; Landires I
    Lancet; 2023 Apr; 401(10385):1339-1340. PubMed ID: 37087169
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rare diseases are common].
    Has C; Giehl K
    Hautarzt; 2014 Jun; 65(6):488-9. PubMed ID: 24898502
    [No Abstract]   [Full Text] [Related]  

  • 3. Next Generation Diagnostics for Rare Neurological Diseases: The Future is Here.
    Innes AM; Boycott KM
    Can J Neurol Sci; 2014 May; 41(3):299-300. PubMed ID: 24718813
    [No Abstract]   [Full Text] [Related]  

  • 4. Collaboration: the foundation for success in rare disease genetic test development.
    Zonno KD; Terry SF
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):553-4. PubMed ID: 19814612
    [No Abstract]   [Full Text] [Related]  

  • 5. Solving the unsolved rare diseases in Europe.
    Graessner H; Zurek B; Hoischen A; Beltran S
    Eur J Hum Genet; 2021 Sep; 29(9):1319-1320. PubMed ID: 34140650
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing for rare conditions.
    Altman N; Krzywinski M
    Nat Methods; 2021 Mar; 18(3):224-225. PubMed ID: 33674793
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidental swimming with millstones.
    Kingsmore SF
    Sci Transl Med; 2013 Jul; 5(194):194ed10. PubMed ID: 23863830
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics. New company pushes the envelope on pre-conception testing.
    Couzin-Frankel J
    Science; 2012 Oct; 338(6105):315-6. PubMed ID: 23087222
    [No Abstract]   [Full Text] [Related]  

  • 9. 23andMe resumes giving consumers genetic health information: Company's tests for rare and common diseases aren't diagnostic.
    Am J Med Genet A; 2017 Aug; 173(8):2003-2004. PubMed ID: 28703454
    [No Abstract]   [Full Text] [Related]  

  • 10. Ending the Diagnostic Odyssey-Is Whole-Genome Sequencing the Answer?
    Wu AC; McMahon P; Lu C
    JAMA Pediatr; 2020 Sep; 174(9):821-822. PubMed ID: 32597967
    [No Abstract]   [Full Text] [Related]  

  • 11. Data barriers limit genetic diagnosis.
    Hayden EC
    Nature; 2013 Feb; 494(7436):156-7. PubMed ID: 23407516
    [No Abstract]   [Full Text] [Related]  

  • 12. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels.
    Martin AR; Williams E; Foulger RE; Leigh S; Daugherty LC; Niblock O; Leong IUS; Smith KR; Gerasimenko O; Haraldsdottir E; Thomas E; Scott RH; Baple E; Tucci A; Brittain H; de Burca A; Ibañez K; Kasperaviciute D; Smedley D; Caulfield M; Rendon A; McDonagh EM
    Nat Genet; 2019 Nov; 51(11):1560-1565. PubMed ID: 31676867
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic testing for rare disease diagnosis-where are we now, and where should we be heading? The reflections of a behavioural scientist.
    Lewis C
    Eur J Hum Genet; 2023 Nov; 31(11):1204-1206. PubMed ID: 37528189
    [No Abstract]   [Full Text] [Related]  

  • 14. Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing.
    Kingsmore SF; Dinwiddie DL; Miller NA; Soden SE; Saunders CJ
    Expert Rev Mol Diagn; 2011 Nov; 11(8):855-68. PubMed ID: 22022947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network.
    Reuter CM; Brimble E; DeFilippo C; Dries AM; ; Enns GM; Ashley EA; Bernstein JA; Fisher PG; Wheeler MT
    J Pediatr; 2018 May; 196():291-297.e2. PubMed ID: 29331327
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosing rare diseases after the exome.
    Frésard L; Montgomery SB
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?
    Liu Z; Zhu L; Roberts R; Tong W
    Trends Genet; 2019 Nov; 35(11):852-867. PubMed ID: 31623871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers.
    Boycott KM; Hartley T; Biesecker LG; Gibbs RA; Innes AM; Riess O; Belmont J; Dunwoodie SL; Jojic N; Lassmann T; Mackay D; Temple IK; Visel A; Baynam G
    Cell; 2019 Mar; 177(1):32-37. PubMed ID: 30901545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicine: Last chance clinic.
    Maher B
    Nature; 2009 Aug; 460(7259):1071-5. PubMed ID: 19713908
    [No Abstract]   [Full Text] [Related]  

  • 20. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
    Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H;
    Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.